In regard to the association of leptin receptor and endometrial carcinoma, Sharma, and associates (2006) found that leptin treatment resulted in the increase of type-I Ishikawa/ECC1 endometrial carcinoma cells that respond to the hormone (18). The gene discussed is LEPR; the disease is endometrial carcinoma.